Weiss Ratings Reiterates “Hold (C)” Rating for Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR)‘s stock had its “hold (c)” rating reaffirmed by Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.

SMLR has been the subject of several other reports. Benchmark decreased their target price on Semler Scientific from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Tuesday, September 23rd. Cantor Fitzgerald decreased their target price on Semler Scientific from $61.00 to $60.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Finally, Maxim Group decreased their target price on Semler Scientific from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Friday, September 19th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $74.25.

Semler Scientific Stock Up 5.3%

Shares of SMLR opened at $23.96 on Friday. Semler Scientific has a 52-week low of $21.84 and a 52-week high of $81.56. The company has a market cap of $362.75 million, a PE ratio of 9.86 and a beta of 1.41. The business has a fifty day moving average of $28.63 and a 200 day moving average of $33.97. The company has a quick ratio of 0.58, a current ratio of 0.60 and a debt-to-equity ratio of 0.25.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Monday, August 4th. The company reported $5.04 earnings per share for the quarter, topping the consensus estimate of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.The business had revenue of $8.22 million during the quarter, compared to the consensus estimate of $8.10 million.

Institutional Trading of Semler Scientific

Several institutional investors and hedge funds have recently made changes to their positions in the company. SummerHaven Investment Management LLC raised its holdings in shares of Semler Scientific by 2.0% in the second quarter. SummerHaven Investment Management LLC now owns 23,570 shares of the company’s stock valued at $913,000 after acquiring an additional 464 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its holdings in shares of Semler Scientific by 10.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 6,226 shares of the company’s stock valued at $225,000 after acquiring an additional 576 shares in the last quarter. SBI Securities Co. Ltd. raised its holdings in shares of Semler Scientific by 161.3% in the first quarter. SBI Securities Co. Ltd. now owns 959 shares of the company’s stock valued at $35,000 after acquiring an additional 592 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Semler Scientific by 15.6% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,582 shares of the company’s stock valued at $178,000 after acquiring an additional 617 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey raised its holdings in shares of Semler Scientific by 75.5% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 1,674 shares of the company’s stock valued at $65,000 after acquiring an additional 720 shares in the last quarter. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.